Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI.
Chan Joo LeeTyler Hyung Taek RimHyun Goo KangJoseph Keunhong YiGeunyoung LeeMarco YuSoo-Hyun ParkJin-Taek HwangYih-Chung ThamTien-Yin WongChing-Yu ChengDong Wook KimSung Soo KimChan Joo LeePublished in: Journal of the American Medical Informatics Association : JAMIA (2023)
These results led the Korean regulatory body to authorize Reti-CVD.
Keyphrases
- deep learning
- cardiovascular disease
- optical coherence tomography
- phase iii
- diabetic retinopathy
- study protocol
- electronic health record
- clinical trial
- transcription factor
- phase ii
- big data
- artificial intelligence
- convolutional neural network
- type diabetes
- machine learning
- optic nerve
- cardiovascular risk factors
- open label
- randomized controlled trial
- cardiovascular events
- metabolic syndrome
- data analysis
- light emitting